The clinical development landscape: A more integrated future
The first half of 2026 has brought renewed momentum to clinical development. In his latest article, Evestia Clinical’s Chief Executive Officer, Lewis Cameron, explores how clinical development is evolving as scientific innovation, regulatory change, and operational delivery become increasingly interconnected. He discusses the growing importance of integrating therapeutic expertise, regulatory strategy, and operational planning from the outset to help biotech companies navigate complexity and accelerate the development of innovative therapies.
Related News
